2215-76-1

Basic information

• Product Name: 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96
• Synonyms: 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96;4,4μ-Diformyldiphenyl ether, 4,4μ-Oxybis(benzaldehyde), 4,4μ-Oxydibenzaldehyde, Bis(4-formylphenyl) ether;4-(4-ForMylphenoxy)benzaldehyde 96%
• CAS NO: 2215-76-1
• Molecular Formula: C₁₄H₁₀O₃
• Molecular Weight: 226.23
• Mol File: 2215-76-1.mol
• Article Data: 15

Chemical Properties

• Melting Point: 63-67 °C
• Boiling Point: 160°C/0.1mmHg(lit.)
• Flash Point: 173.1 °C
• Appearance: /
• Density: 1.233
• Solubility: soluble in Toluene
• CAS DataBase Reference: 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96(2215-76-1)
• EPA Substance Registry System: 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96(2215-76-1)

Safety Data

• Hazard Codes: Xn
• Statements: 22-36-43
• Safety Statements: 26-36/37
• WGK Germany: 2
• Hazardous Substances Data: 2215-76-1(Hazardous Substances Data)

Usage

General Description

4-(4-Formylphenoxy)benzaldehyde 96 is a chemical compound with the formula C14H10O3. It is a benzaldehyde derivative with a formyl group attached to a phenoxy group on the 4-position of the benzene ring. 4-(4-FORMYLPHENOXY)BENZALDEHYDE 96 is commonly used in organic synthesis as a building block for the production of various pharmaceuticals, agrochemicals, and other fine chemicals. It can also be used as a reagent for the preparation of other organic compounds. 4-(4-Formylphenoxy)benzaldehyde 96 is a yellow crystalline solid that has a molecular weight of 226.22 g/mol and is usually handled and stored under proper laboratory conditions due to its potential irritant and flammable properties.

Upstream product

• 100-97-0 hexamethylenetetramine 
• 4542-75-0 4,4'-oxybis-((bromomethyl)benzene) 
• 7158-32-9 4,4'-bis(chlorocarbonyl)diphenyl oxide 
• 1579-40-4 1,1'-oxybis(4-methyl-benzene) 
• 555-16-8 4-nitrobenzaldehdye 
• 123-08-0 4-hydroxy-benzaldehyde 
• 99-96-7 4-hydroxy-benzoic acid 
• 3096-86-4 4,4'-oxybis(ethyl benzoate) 
• 2350-43-8 4,4'-oxy-bis(4,1-phenylene) dimethanol 
• 586-76-5 4-Bromobenzoic acid 
• 5798-75-4 Ethyl 4-bromobenzoate 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 2050-47-7 4,4'-dibromodiphenyl ether 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 27363-28-6 4,4'-oxy-di-benzaldehyde bis-phenylimine 
• 90178-69-1 4,4'-Bis(4-cyan-2-nitrostyryl)diphenylether 
• 3525-58-4 4,4'-Bis-(4-methoxy-phenyliminomethyl)-diphenylaether 
• 3906-51-2 4,4'-Bis-(4-carboxy-phenyliminomethyl)-diphenylether 
• 3806-08-4 4.4'-Bis-(3-hydroxy-4-methoxycarbonyl-phenyliminomethyl)-diphenylaether 
• 7158-32-9 4,4'-bis(chlorocarbonyl)diphenyl oxide 
• 1187680-32-5 C₃₀H₁₈N₄O₅ 
• 1240356-67-5 C₅₂H₄₆N₈O₇S₂ 
• 1240356-54-0 C₂₈H₂₄N₂O₇S₂ 
• 1239620-71-3 C₂₆H₃₈N₄O₅ 
• 1266348-22-4 (2E,2'E)-3,3'-(4,4'-oxybis(4,1-phenylene))-bis(1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one) 

Relevant articles and documents

Bis-Benzyl-Tetrahydroisoquinoline Derivatives As Therapeutics For Filovirus

Bis-benzyl-tetrahydroisoquinoline analogs that are derivatives of the cyclic products tetrandrine (TETN) and cepharanthine (CEPH). The analogs indicate activity against filovirus infections, including the type species Marburg virus (MARV) and Ebola virus (EBOV).

Styrene-based compound and preparation method and application thereof

The invention discloses a styrene-based compound, which is at least a 5-(4-(4-(3,5-dyhydroxystyryl)phenoxyl)styryl)-1,3-benzenediol compound of the following structural formula. The invention also discloses a preparation method and application of the 5-(4-(4-(3,5-dyhydroxystyryl)phenoxyl)styryl)-1,3-benzenediol compound of the structural formula. The 5-(4-(4-(3,5-dyhydroxystyryl)phenoxyl)styryl)-1,3-benzenediol compound disclosed by the invention is used for inhibiting the abnormal growth of B-cells by lowering AKT/mTOR signal conduction. The formula is shown in the specification.

Y-shaped bis-arylethenesulfonic acid esters: Potential potent and membrane permeable protein tyrosine phosphatase 1B inhibitors

Known PTP1B inhibitors with bis-anionic moieties exhibit potent inhibitory activity, good selectivity, however, they are incapable of penetrating cellular membranes. Based upon our finding of a new pharmacophoric group in inhibition of PTP1B and the struc